CardieX Limited (AU:CDX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
CardieX Limited has reported a record financial year with $12.4 million in revenue, doubling from the previous year, and is poised for further growth with the introduction of the CONNEQT Pulse device in the USA and Australia. The company’s robust product pipeline and strategic partnerships, like with PhysioAge, are expected to contribute to continued revenue growth and market expansion. CardieX’s targeted marketing initiatives and increased production of the Pulse units indicate a strong market demand and a commitment to innovation in healthcare technology.
For further insights into AU:CDX stock, check out TipRanks’ Stock Analysis page.
